Vaccine Allocation Priorities Using Disease Surveillance and Economic Data

Anup Malani, Satej Soman, Sabareesh Ramachandran, Alice Chen and Darius Lakdawalla

No 29682, NBER Working Papers from National Bureau of Economic Research, Inc

Abstract: Vaccination is a critical tool, along with suppression and treatment, for controlling epidemics such as SARS-CoV-2. To maximize the impact of vaccination, doses should be allocated to the highest value targets, accounting for health and potential economic benefits. We examine what allocation strategy is optimal and how to translate that strategy into actionable procurement decisions in the context of India. We compare 3 different allocation strategies (oldest first, highest contact rate first, random order) across 4 outcomes (lives saved, life-years saved, value of statistical lives saved, value of statistical life-years saved). We make 3 methodological contributions. First, we estimate the incremental health benefit of vaccination using novel, local seroprevalence data from India. Second, we estimate the value of statistical life-years using disaggregated, monthly data on consumption during the pandemic. Third, and most importantly, we estimate social demand curves for vaccines that can practically guide government procurement decisions. Our analysis yields 4 novel findings. First, the need to speed-up vaccination does not justify deviation from elderly-first prioritization. Second, much of the value of vaccination comes from improvements in consumption rather than longevity. Moreover, vaccination increases the value of a life year because it increases consumption. Third, social demand for vaccination falls over time as natural immunity from infections increases. Therefore, the slower a country vaccinates its population, the fewer doses it should procure. Fourth, there is enough variation in consumption and infection risk that it makes sense to vaccinate some areas before others. Our approach of connecting epidemiological models and data on health and consumption to economic valuation methods generalizes to other infection control strategies, such as suppression, and public health crises, such as influenza and HIV.

JEL-codes: I1 I18 (search for similar items in EconPapers)
Date: 2022-01
New Economics Papers: this item is included in nep-hea
Note: DEV EH
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
http://www.nber.org/papers/w29682.pdf (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nbr:nberwo:29682

Ordering information: This working paper can be ordered from
http://www.nber.org/papers/w29682

Access Statistics for this paper

More papers in NBER Working Papers from National Bureau of Economic Research, Inc National Bureau of Economic Research, 1050 Massachusetts Avenue Cambridge, MA 02138, U.S.A.. Contact information at EDIRC.
Bibliographic data for series maintained by ().